[1] PAGANETTI H, Proton Therapy Physics[M]. Boca Raton:CRC Press, 2012:20.
[2] LIU SHIYAO, Proton and Heavy Ion Therapy and the Devices[M]. Beijing:Science Press, 2012:17. (in chinese) (刘世耀. 质子和重离子治疗及其装置[M]. 北京:科学出版社, 2012:17.)
[3] LUNDKVIST J, EKMAN M, ERICSSON S R, et al. Acta oncologica, 2005, 44(8):850.
[4] JERMANN M. International Journal of Particle Therapy, 2015, 2(1):50.
[5] ROSSI JR C J. Intensity-Modulated Proton Beam Therapy of Prostate Cancer-History, Results, and Future Directions[M]//WONG J, SCHUTHEISS T, RADANY E. Advances in Radiation Oncology, Berlin:Springer International Publishing, 2017:109.
[6] JONGEN Y. Review on Cyclotrons for Cancer Therapy[C]. Proceedings of Cyclotrons 2010:58.
[7] WIESZCZYCKA W, SCHARF W H. Proton radiotherapy accelerators[M]. Singapore:World Scientific, 2001:17.
[8] KOSTROMIN S, GURSKY S, KARAMYSHEVA G, et al. Development of the IBA-JINR cyclotron C235-V3 for Dimitrovgrad Hospital Center of the Proton Therapy[C]. Proc of RUPAC, 2012:221.
[9] LEE S K, LEE H R, KIM K R, et al. Characteristic Experimentations of Degrader and Scatterer at MC-50 Cyclotron[C]. Particle Accelerator Conference, PAC 2005, Proceedings of the IEEE, 2005:1356.
[10] SCHILLO M, GEISLER A, HOBL A, et al. Compact Superconducting 250 MeV Proton Cyclotron for the PSI Proscan Proton Therapy Project[C]. AIP Conference Proceedings, 2001, 600(1):37.
[11] PEDRONI E, BACHER R, BLATTMANN H, et al. Medical Physics, 1995, 22(1):37.
[12] REIST H, DOLLING R, GRAF M, et al. A Fast Degrader to set the Energies for the Application of the Depth Dose in Proton Therapy[C]. Scientific and Technical Report 2001, 2002:20.
[13] CASCIO E W, SARKAR S. A Continuously Variable Water Beam Degrader for the Radiation Test Beamline at the Francis H. Burr Proton Therapy Center[C]. Radiation Effects Data Workshop, IEEE, 2007:30.
[14] OWEN H, HOLDER D, ALONSO J, et al. International Journal of Modern Physics A, 2014, 29(14):1441002.
[15] STICHELBAUT F, JONGEN Y. Properties of an energy degrader for light ions[C]. Progress in Nuclear Science and Technology, 2014, 4:272.
[16] BRENNSETER J A. The Influence of the Energy Degrader Material for a Therapeutical Proton Beam[D]. Norway:Norwegian University of Science and Technology, 2015:5.
[17] ANFEROV V. Nucl Instr Meth A, 2003, 496(1):222.
[18] VAN GOETHEM M J, VAN D M R, REIST H W, et al. Physics in Medicine and Biology, 2009, 54(54):5831.
[19] GERBERSHAGEN A, BAUMGARTEN C, KISELEV D, et al. Physics in Medicine and Biology, 2016, 61(14):N337.
[20] PAGANETTI H, JIANG H, LEE S Y, et al. Medical Physics, 2004, 31(7):2107.
[21] PERL J, SHIN J, SCHUMANN J, et al. Medical Physics, 2012, 39(11):6818.
[22] TESTA M, SCHUMANN J, LU H M, et al. Medical Physics, 2013, 40(12):121719.
[23] PERL J. User Guide for TOPAS Version 3.0(rev. 201605-22b). 2016:72.
[24] ASO T, KIMURA A, TANAKA S, et al. IEEE transactions on Nuclear Science, 2005, 52(4):896.
[25] Geant4 Collaboration. geant4 User's Guide for Application Developers[EB/OL].[2014-12-5].
[26] JARLSKOG C Z, PAGANETTI H. IEEE Transactions on Nuclear Science, 2008, 55(3):1018.
[27] PAGANETTI H. Physics in Medicine and Biology, 2012, 57(11):R99.
[28] URBAN T, KLUSON J. Radioprotection, 2012, 47(04):583.